Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
作者信息
Ferro Matteo, Caputo Vincenzo Francesco, Barone Biagio, Imbimbo Ciro, de Cobelli Ottavio, Crocetto Felice
机构信息
Department of Urology, IRCCS European Institute of Oncology (IEO), Milan, Italy.
Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
出版信息
Front Oncol. 2021 Sep 9;11:754649. doi: 10.3389/fonc.2021.754649. eCollection 2021.
Abstract
摘要
相似文献
1
Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?淋巴细胞与单核细胞比值：膀胱癌进展中的一个新的独立预后因素？
Front Oncol. 2021 Sep 9;11:754649. doi: 10.3389/fonc.2021.754649. eCollection 2021.
2
Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.基于炎症的预处理预后评分（中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值以及淋巴细胞与单核细胞比值）对浸润性膀胱癌的预测价值。
Korean J Urol. 2015 Nov;56(11):749-55. doi: 10.4111/kju.2015.56.11.749. Epub 2015 Nov 3.
3
[Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].[术前淋巴细胞与单核细胞比值预测T1期非肌层浸润性膀胱癌患者的预后]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):622-629. doi: 10.3881/j.issn.1000-503X.11227.
4
: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer.一种预测非肌层浸润性膀胱癌进展风险的新型分子标志物。
Oncol Lett. 2019 Oct;18(4):3471-3480. doi: 10.3892/ol.2019.10706. Epub 2019 Aug 2.
5
Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.非肌肉浸润性膀胱癌和肌肉浸润性膀胱癌预后和差异表达基因的比较生物信息学分析。
J Proteomics. 2020 Oct 30;229:103951. doi: 10.1016/j.jprot.2020.103951. Epub 2020 Aug 27.
6
Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer.免疫组织化学生物标志物在非肌肉浸润性膀胱癌和肌肉浸润性膀胱癌中的预后意义。
Mini Rev Med Chem. 2020;20(12):1133-1152. doi: 10.2174/1389557516666160512151202.
7
History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.肌层浸润性膀胱癌病史可能对接受根治性膀胱切除术治疗的 cT2-4aN0M0 膀胱癌患者的预后产生更差的影响。
Clin Genitourin Cancer. 2018 Oct;16(5):e969-e976. doi: 10.1016/j.clgc.2018.04.004. Epub 2018 Apr 28.
8
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.高危非肌肉浸润性膀胱癌患者的系统性炎症标志物与肿瘤学结局。
Eur Urol Oncol. 2018 Oct;1(5):403-410. doi: 10.1016/j.euo.2018.06.006. Epub 2018 Jul 13.
9
Prognostic value of preoperative inflammation markers in non-muscle invasive bladder cancer.术前炎症标志物在非肌肉浸润性膀胱癌中的预后价值。
Int J Clin Pract. 2021 Jun;75(6):e14118. doi: 10.1111/ijcp.14118. Epub 2021 Mar 5.
10
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.前瞻性评估膀胱影像报告和数据系统（VI-RADS）及其对高危非肌肉浸润性膀胱癌患者重复经尿道切除术候选者管理的临床影响。
Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov 5.
引用本文的文献
1
LAR, FAR, and PLR as prognostic factors in high-grade urothelial carcinoma of the bladder after surgery.LAR、FAR和PLR作为膀胱高级别尿路上皮癌术后的预后因素。
Front Oncol. 2025 Mar 11;15:1566848. doi: 10.3389/fonc.2025.1566848. eCollection 2025.
2
The relationship between complete blood cell count-derived inflammatory biomarkers and erectile dysfunction in the United States.美国全血细胞计数衍生的炎症生物标志物与勃起功能障碍之间的关系。
Sci Rep. 2024 Dec 30;14(1):32014. doi: 10.1038/s41598-024-83733-5.
3
Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer.术后 C 反应蛋白与白蛋白比值是胃癌的独立预后因素。
Eur J Med Res. 2023 Sep 21;28(1):360. doi: 10.1186/s40001-023-01334-w.
4
Prognostic impact of geriatric nutritional risk index on patients with urological cancers: A meta-analysis.老年营养风险指数对泌尿系统癌症患者的预后影响：一项荟萃分析。
Front Oncol. 2023 Jan 11;12:1077792. doi: 10.3389/fonc.2022.1077792. eCollection 2022.
5
Preoperative Fibrinogen-to-Albumin Ratio as Potential Predictor of Bladder Cancer: A Monocentric Retrospective Study.术前纤维蛋白原-白蛋白比值作为膀胱癌的潜在预测指标：一项单中心回顾性研究。
Medicina (Kaunas). 2022 Oct 19;58(10):1490. doi: 10.3390/medicina58101490.
6
The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.全身免疫炎症指数和中性粒细胞与淋巴细胞比值在预测局限性前列腺癌患者根治性前列腺切除术后生化复发中的价值
Front Oncol. 2022 Jun 2;12:907625. doi: 10.3389/fonc.2022.907625. eCollection 2022.
7
Treatment Strategy for Dialysis Patient with Urothelial Carcinoma.尿路上皮癌透析患者的治疗策略
Diagnostics (Basel). 2021 Oct 22;11(11):1966. doi: 10.3390/diagnostics11111966.
本文引用的文献
1
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy.中性粒细胞与白蛋白比值可预测接受新辅助化疗后行根治性膀胱切除术的膀胱癌患者的死亡率。
Future Sci OA. 2021 Apr 20;7(7):FSO709. doi: 10.2144/fsoa-2021-0008. eCollection 2021 Aug.
2
Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer.淋巴细胞与单核细胞比值是接受卡介苗免疫治疗的膀胱癌患者病情进展的独立预后标志物。
Front Oncol. 2021 Mar 26;11:655000. doi: 10.3389/fonc.2021.655000. eCollection 2021.
3
Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer.尿液中的液体活检生物标志物：膀胱癌分子诊断与个性化医疗之路。
J Pers Med. 2021 Mar 23;11(3):237. doi: 10.3390/jpm11030237.
4
Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy.术前淋巴细胞与单核细胞比值对根治性膀胱切除术后膀胱癌患者生存结局的预测价值。
J Cancer. 2021 Jan 1;12(2):305-315. doi: 10.7150/jca.50603. eCollection 2021.
5
Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single-center experience with 10-year outcomes.腹腔镜根治性膀胱切除术联合体外尿流改道术：意大利单中心10年随访结果
Minerva Urol Nefrol. 2020 Oct;72(5):641-643. doi: 10.23736/S0393-2249.20.03850-3. Epub 2020 Jun 16.
6
Epidemiology of Bladder Cancer.膀胱癌流行病学
Med Sci (Basel). 2020 Mar 13;8(1):15. doi: 10.3390/medsci8010015.
7
Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals.淋巴细胞与单核细胞比值对行根治性膀胱切除术的膀胱癌患者预后的意义：5638 例个体的荟萃分析。
Dis Markers. 2019 Apr 4;2019:7593560. doi: 10.1155/2019/7593560. eCollection 2019.
8
Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.血小板与淋巴细胞比值对胆管癌的预后意义：一项荟萃分析。
Biomed Res Int. 2018 Nov 14;2018:7375169. doi: 10.1155/2018/7375169. eCollection 2018.
9
The High-Sensitivity C-Reactive Protein/Albumin Ratio Predicts Long-Term Oncologic Outcomes after Curative Resection for Hepatocellular Carcinoma.高敏C反应蛋白与白蛋白比值可预测肝细胞癌根治性切除术后的长期肿瘤学结局。
J Clin Med. 2018 Jun 7;7(6):139. doi: 10.3390/jcm7060139.
10
Prediction models for progression of non-muscle-invasive bladder cancer: A review.非肌层浸润性膀胱癌进展的预测模型：综述
Int J Urol. 2018 Mar;25(3):212-218. doi: 10.1111/iju.13509. Epub 2017 Dec 16.
Zotero 插件